Organic & Biomolecular Chemistry
Communication
0
.25 µM and 1 µM and incubated for 2 h at the same con-
ditions or on ice. Cells were washed with PBS and detached
with Na EDTA. Cells were re-suspended in PBS and added to
2 E. Pazos, J. Mosquera, M. E. Vázquez and J. L. Mascareñas,
ChemBioChem, 2011, 12, 1958–1973.
3 N. M. Luscombe, S. E. Austin, H. M. Berman and
J. M. Thornton, Genome Biol., 2000, 1, 1–10.
4 L. L. G. Carrette, T. Morii and A. Madder, Eur. J. Org.
Chem., 2014, 14, 2883–2891.
4
the BD Accuri flow cytometer. Experiments were carried out in
duplicate.
MTT assay
5
T. Morii, M. Simomura and S. Morimoto, J. Am. Chem. Soc.,
1993, 32, 1150–1151.
4
RAW264.7 cells cultivated in DMEM (10 per well, 200 µL) were
plated in a 96-well plates and incubated overnight at 37 °C and
6 A. M. Vázquez, M. Eugenio and J. L. Mascareñas, Angew.
Chem., Int. Ed., 2000, 112, 3234–3237.
5
% CO . The peptides and control compounds were added in
2
an overall concentration of 0.25 µM and 1 µM and incubated
for 24 h under the same conditions. The MTT solution was
then added to the aspirated wells and incubated for 3 h. After
removal of the cell medium, purple formazan crystals were dis-
solved in DMSO. Then, UV-measurement at 570 nm was per-
formed with a plate reader to check cell viability quantitatively.
7 M. I. N. Zhang, B. Wu, H. Zhao and J. W. Taylor, J. Pept.
Sci., 2002, 136, 125–136.
8 C. Park, J. L. Campbell and W. A. Goddard, J. Am. Chem.
Soc., 1996, 118, 4235–4239.
9 L. K. Henchey, A. L. Jochim and P. S. Arora, Curr. Opin.
Chem. Biol., 2008, 12, 22–26.
An observation with the naked eye already gave a good idea 10 J. Mosquera, A. Jiménez-Balsa, V. I. Dodero,
about the toxicity of the compounds due to the disappearance
of color in the well. Comparison of the absorbance of the for-
M. E. Vázquez and J. L. Mascareñas, Nat. Commun.,
2013, 4, 1874.
mazan solution of the sample to the absorbance of a positive 11 K. Estieu-gionnet and G. Guichard, Drug Discovery, 2011, 6,
control (incubation with DMSO) and a negative control (incu-
937–963.
bation with ultrapure water) gave quantitative results of cell 12 M. M. Madden, A. Muppidi, Z. Li, X. Li, J. Chen
viability as in the equation:
and Q. Lin, Bioorg. Med. Chem. Lett., 2011, 21,
472–1475.
1
A ꢀ Apos
Cell viability ð%Þ ¼
ꢁ 100
1
1
1
3 H. Inhibitor, H. Zhang, Q. Zhao, S. Bhattacharya,
A. A. Waheed, X. Tong, A. Hong, S. Heck, F. Curreli,
M. Goger, D. Cowburn, E. O. Freed and A. K. Debnath,
J. Mol. Biol., 2008, 378, 565–580.
4 C. J. Brown, S. T. Quah, J. Jong, A. M. Goh, P. C. Chiam,
K. H. Khoo, M. L. Choong, M. a. Lee, L. Yurlova,
K. Zolghadr, T. L. Joseph, C. S. Verma and D. P. Lane, ACS
Chem. Biol., 2013, 8, 506–512.
Aneg ꢀ Apos
Peptide stability
Peptides dissolved in a 50 mM NH
4
HCO
3
buffer at a concen-
−
1
tration of 0.5 mg mL are incubated at 37 °C with a trypsin
solution (trypsin/peptide: 1/1000 wt%) in AcOH 50 mM buffer.
The pH was optimized to 7–9. Samples were taken after 0 min,
0 min, 1 h, 2 h and 24 h and injected on RP-HPLC (Jupiter C4
00A, 0–100% CH CN in 15 min). Peaks were collected and
3
3
5 H. Jo, N. Meinhardt, Y. Wu, S. Kulkarni, X. Hu,
K. E. Low, P. L. Davies, W. F. DeGrado and
D. C. Greenbaum, J. Am. Chem. Soc., 2012, 134, 17704–
3
analysed using MALDI-TOF. Peaks were integrated. The peak
area at 0 min was used as control.
1
7713.
6 Y.-W. Kim, T. N. Grossmann and G. L. Verdine, Nat. Protoc.,
011, 6, 761–771.
1
1
2
Acknowledgements
7 Ø. Jacobsen, H. Maekawa, N. Ge, C. H. Görbitz and
P. Rongved, J. Org. Chem., 2011, 76, 1228–1238.
8 W. S. Horne, Chem. Commun., 2011, 47, 1–4.
9 Y. Demizu, N. Yamagata, S. Nagoya, Y. Sato and M. Doi,
Tetrahedron, 2011, 67, 6155–6165.
0 L. D. Walensky and G. H. Bird, J. Med. Chem., 2014, 57,
Tim Courtin is acknowledged for the determination of the con-
centration of the final compounds by ERECTIC-NMR. Ellen
Gyssels is thanked for her assistance in determining the con-
centration of the DNA strands and fluorescently labeled pep-
tides using the Trinean DropSense 96. Jan Goeman is
acknowledged for the LC-MS analysis. Abhishek Iyer and Yara
Ruiz García are indebted to the Marie Curie Early Stage
Research Training Fellowship of the European Community’s
Seventh Framework Programme under contract number
PITN-GA-2010-238679. The FWO and BOF are also acknowl-
edged for financial support.
1
1
2
2
2
6275–6288.
1 T. E. Ellenberger, C. J. Brandl, K. Struhl and S. C. Harrison,
Cell, 1992, 71, 1223–1237.
2 A. Jimønez-balsa, E. Pazos, B. Martínez-albardonedo,
J. L. Mascareñas and M. E. Vázquez, Angew. Chem., Int. Ed.,
2
012, 51, 8825–8829.
3 W. Keller, P. Ko and T. J. Richmond, J. Mol. Biol., 1995, 254,
57–667.
4 N. J. Zondlo and A. Schepartz, J. Am. Chem. Soc., 1999, 121,
938–6939.
2
2
6
Notes and references
6
1
D. S. Latchman, Eukaryotic Transcription Factors, Elsevier, 25 L. Guerrero, O. S. Smart, G. A. Woolley and R. K. Allemann,
London, 5th edn, 2011, ch. 1, p. 1. J. Am. Chem. Soc., 2005, 127, 15624–15629.
This journal is © The Royal Society of Chemistry 2015
Org. Biomol. Chem., 2015, 13, 3856–3862 | 3861